AgResearch
Browse
Mass Spec Reviews 38(3)_253-264 - EMaes_et_al 010619.pdf (314.22 kB)

The challenges of peptidomics in complementing proteomics in a clinical context

Download (314.22 kB)
journal contribution
posted on 2023-05-03, 17:20 authored by Evelyne MaesEvelyne Maes, Eline Oeyen, Kurt Boonen, Karin Schildermans, Inge Mertens, Patrick Pauwels, Dirk Valkenborg, Geert Baggerman
Naturally occurring peptides, including growth factors, hormones, and neurotransmitters, represent an important class of biomolecules and have crucial roles in human physiology. The study of these peptides in clinical samples is therefore as relevant as ever. Compared to more routine proteomics applications in clinical research, peptidomics research questions are more challenging and have special requirements with regard to sample handling, experimental design, and bioinformatics. In this review, we describe the issues that confront peptidomics in a clinical context. After these hurdles are (partially) overcome, peptidomics will be ready for a successful translation into medical practice.

History

Rights statement

© 2018 by Wiley Periodicals, Inc.

Language

  • English

Does this contain Māori information or data?

  • No

Publisher

Wiley

Journal title

Mass Spectrometry Reviews

ISSN

0277-7037

Citation

Maes, E., Oeyen, E., Boonen, K., Schildermans, K., Mertens, I., Pauwels, P., … Baggerman, G. (2019). The challenges of peptidomics in complementing proteomics in a clinical context. Mass Spectrometry Reviews, 38(3), 253–264. doi:10.1002/mas.21581|

Usage metrics

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC